drugset / Trial / NCT00163111

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

NCT00163111

Phase 3 Completed 412 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients

Timeline

Start
1998-09
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown
Subject Fluconazole Small molecule Intravenous
Subject Voriconazole Small molecule Intravenous

Indications